Universal CAR-T cells tested as potential new weapon against severe lupus
Disease control
Recruiting now
This early-phase study is testing a new cell therapy called QT-019B for people with severe lupus that hasn't responded to standard treatments. The therapy uses 'universal' CAR-T cells from healthy donors, designed to target and remove certain immune cells thought to drive lupus. …
Phase: PHASE1 • Sponsor: Hangzhou Qihan Biotech Co., Ltd. • Aim: Disease control
Last updated Mar 16, 2026 15:23 UTC